JCR Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 3/6
JCR Pharmaceuticals has a total shareholder equity of ¥57.0B and total debt of ¥28.4B, which brings its debt-to-equity ratio to 49.8%. Its total assets and total liabilities are ¥104.6B and ¥47.6B respectively.
Key information
49.8%
Debt to equity ratio
JP¥28.41b
Debt
| Interest coverage ratio | n/a |
| Cash | JP¥18.27b |
| Equity | JP¥57.05b |
| Total liabilities | JP¥47.57b |
| Total assets | JP¥104.62b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: JCR's short term assets (¥56.3B) exceed its short term liabilities (¥34.1B).
Long Term Liabilities: JCR's short term assets (¥56.3B) exceed its long term liabilities (¥13.4B).
Debt to Equity History and Analysis
Debt Level: JCR's net debt to equity ratio (17.8%) is considered satisfactory.
Reducing Debt: JCR's debt to equity ratio has increased from 27.8% to 49.8% over the past 5 years.
Debt Coverage: JCR's debt is not well covered by operating cash flow (16.5%).
Interest Coverage: Insufficient data to determine if JCR's interest payments on its debt are well covered by EBIT.